184 related articles for article (PubMed ID: 9060691)
1. Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).
Pleskoff O; Sol N; Labrosse B; Alizon M
J Virol; 1997 Apr; 71(4):3259-62. PubMed ID: 9060691
[TBL] [Abstract][Full Text] [Related]
2. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.
Brelot A; Heveker N; Pleskoff O; Sol N; Alizon M
J Virol; 1997 Jun; 71(6):4744-51. PubMed ID: 9151868
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB).
Strizki JM; Turner JD; Collman RG; Hoxie J; González-Scarano F
J Virol; 1997 Jul; 71(7):5678-83. PubMed ID: 9188648
[TBL] [Abstract][Full Text] [Related]
5. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.
Deichmann M; Kronenwett R; Haas R
Blood; 1997 May; 89(10):3522-8. PubMed ID: 9160656
[TBL] [Abstract][Full Text] [Related]
6. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
[TBL] [Abstract][Full Text] [Related]
7. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
[TBL] [Abstract][Full Text] [Related]
8. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
[TBL] [Abstract][Full Text] [Related]
9. Role of the amino-terminal extracellular domain of CXCR-4 in human immunodeficiency virus type 1 entry.
Picard L; Wilkinson DA; McKnight A; Gray PW; Hoxie JA; Clapham PR; Weiss RA
Virology; 1997 Apr; 231(1):105-11. PubMed ID: 9143308
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.
Delézay O; Koch N; Yahi N; Hammache D; Tourres C; Tamalet C; Fantini J
AIDS; 1997 Sep; 11(11):1311-8. PubMed ID: 9302439
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection.
Baiocchi M; Olivetta E; Chelucci C; Santarcangelo AC; Bona R; d'Aloja P; Testa U; Komatsu N; Verani P; Federico M
Blood; 1997 Apr; 89(8):2670-8. PubMed ID: 9108384
[TBL] [Abstract][Full Text] [Related]
12. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.
Isaka Y; Sato A; Miki S; Kawauchi S; Sakaida H; Hori T; Uchiyama T; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1999 Nov; 264(1):237-43. PubMed ID: 10544150
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
14. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
[TBL] [Abstract][Full Text] [Related]
15. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
Kato K; Sato H; Takebe Y
J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
[TBL] [Abstract][Full Text] [Related]
16. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
17. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
18. CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry.
Tachibana K; Nakajima T; Sato A; Igarashi K; Shida H; Iizasa H; Yoshida N; Yoshie O; Kishimoto T; Nagasawa T
J Exp Med; 1997 May; 185(10):1865-70. PubMed ID: 9151712
[TBL] [Abstract][Full Text] [Related]
19. CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: the role of the N-terminal domain of CXCR-4 in fusion and entry.
Potempa S; Picard L; Reeves JD; Wilkinson D; Weiss RA; Talbot SJ
J Virol; 1997 Jun; 71(6):4419-24. PubMed ID: 9151832
[TBL] [Abstract][Full Text] [Related]
20. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
